You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

List of Excipients in API eszopiclone


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing eszopiclone

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Rebel Distributors Corp LUNESTA eszopiclone 21695-225 ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Rebel Distributors Corp LUNESTA eszopiclone 21695-225 CELLULOSE, MICROCRYSTALLINE
Rebel Distributors Corp LUNESTA eszopiclone 21695-225 CROSCARMELLOSE SODIUM
Rebel Distributors Corp LUNESTA eszopiclone 21695-225 HYPROMELLOSE 2910
Rebel Distributors Corp LUNESTA eszopiclone 21695-225 LACTOSE MONOHYDRATE
Rebel Distributors Corp LUNESTA eszopiclone 21695-225 MAGNESIUM STEARATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Try a Trial

Excipients in ANDA-approved (generic) drugs containing eszopiclone

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc eszopiclone 0093-5537 ANHYDROUS DIBASIC CALCIUM PHOSPHATE
Teva Pharmaceuticals USA Inc eszopiclone 0093-5537 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc eszopiclone 0093-5537 CROSCARMELLOSE SODIUM
Teva Pharmaceuticals USA Inc eszopiclone 0093-5537 FD&C BLUE NO. 1 ALUMINUM LAKE
Teva Pharmaceuticals USA Inc eszopiclone 0093-5537 HYPROMELLOSE 2910
Teva Pharmaceuticals USA Inc eszopiclone 0093-5537 MAGNESIUM STEARATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Try a Trial

Detailed excipient profiles for eszopiclone

Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE

eszopiclone drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE

Company Ingredient NDC
Mylan Pharmaceuticals Inc eszopiclone 0378-5270
Macleods Pharmaceuticals Limited eszopiclone 33342-299
PD-Rx Pharmaceuticals Inc eszopiclone 43063-795
Aphena Pharma Solutions - Tennessee LLC eszopiclone 43353-101
Aphena Pharma Solutions - Tennessee LLC eszopiclone 43353-200
Medsource Pharmaceuticals eszopiclone 45865-830
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

eszopiclone drug variants containing CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE

Company Ingredient NDC
Macleods Pharmaceuticals Limited eszopiclone 33342-299
Aidarex Pharmaceuticals LLC eszopiclone 53217-151
Quality Care Products LLC eszopiclone 55700-581
Quality Care Products LLC eszopiclone 55700-610
Lake Erie Medical DBA Quality Care Products LLC eszopiclone 55700-621
St Mary's Medical Park Pharmacy eszopiclone 60760-325
>Company >Ingredient >NDC

Subscribe to access the full database, or Try a Trial

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: INDIGOTINDISULFONATE SODIUM

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MICROCRYSTALLINE CELLULOSE

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: POVIDONE

Excipient focus: SILICON DIOXIDE

Excipient focus: STARCH, CORN

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - HIPAA-ready chat for life sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group